marketcaparena
Search

    ACXP

    Acurx Pharmaceuticals, Inc.

    Company overview

    Market capitalization
    $7.06M
    Employees
    4
    Latest publication
    2026-09-29
    About Acurx Pharmaceuticals, Inc.

    Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue0USD0USD0USD0USD0USD0USD0USD0USD
    Research Development341,468USD1,832,953,301USD429,691USD524,210USD598,798USD825,059USD1,198,184USD1,825,582USD
    Selling General Administrative1,374,522,000USD6,254,181,132USD1,599,010USD1,745,473USD1,550,395USD1,956,732USD1,623,413USD2,297,026USD
    Unclassified Operating Expenses-1,373,147,478USD-8,085,517,317USD——————
    Total Operating Expenses1,715,990USD1,617,116USD2,028,701USD2,269,683USD2,149,193USD2,781,791USD2,821,597USD4,122,608USD
    Operating Income-1,715,990USD-1,617,116USD-2,028,701USD-2,269,683USD-2,149,193USD-2,781,791USD-2,821,597USD-4,122,608USD
    Interest Income35,008USD38,840USD35,911USD23,404USD27,291USD—5,001USD782USD
    Net Interest Income35,008USD38,840USD35,911USD23,404USD27,291USD—5,001USD782USD
    Income Before Tax-1,680,982USD-1,578,276USD-1,992,790USD-2,246,279USD-2,149,193USD-2,781,791USD-2,821,597USD-4,121,826USD
    Net Income-1,680,982USD-1,578,276USD-1,992,790USD-2,246,279USD-2,149,193USD-2,781,791USD-2,821,597USD-4,121,826USD
    Net Income From Continuing Ops-1,680,982USD-1,578,276USD-1,992,790USD-2,246,279USD-2,149,193USD-2,781,791USD-2,821,597USD-4,121,826USD
    Ebitda-1,715,990USD-1,617,116USD-2,028,701USD-2,269,683USD-2,149,193USD-2,781,791USD-2,821,597USD-4,122,608USD
    Total Other Income Expense Net35,008USD38,840USD35,911USD23,404USD0USD-2,781,791USD0USD782USD
    Ebit—6,411,666USD—-2,269,683USD-2,149,193USD-2,781,791USD-5,644,000USD-8,244,000USD
    Depreciation And Amortization—-2,149,193USD——2,149,193USD2,781,791USD2,821,597USD4,122,000USD
    Income Tax Expense—————4,378,000USD—-4,121,826USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Revenue0USD0USD0USD0USD0USD0USD0USD
    Research Development1,834,506,000USD5,403,836USD6,043,597USD4,754,271USD2,030,177USD2,202,979USD3,510,088USD
    Selling General Administrative6,257,477,000USD8,699,267USD8,534,171USD7,338,505USD10,784,023USD2,397,059USD2,421,165USD
    Unclassified Operating Expenses-8,083,891,017USD——————
    Total Operating Expenses8,091,983USD14,103,103USD14,577,768USD12,092,776USD12,814,200USD4,600,038USD5,931,253USD
    Operating Income-8,091,983USD-14,103,103USD-14,577,768USD-12,092,776USD-12,880,703USD-4,600,038USD-5,931,253USD
    Interest Income125,445USD20,124USD—————
    Net Interest Income125,445USD20,124USD—————
    Income Before Tax-7,966,538USD-14,103,103USD-14,577,768USD-12,092,776USD-12,747,697USD-4,600,038USD-5,931,253USD
    Net Income-7,966,538USD-14,103,103USD-14,577,768USD-12,092,776USD-12,681,194USD-4,600,038USD-5,931,253USD
    Net Income From Continuing Ops-7,966,538USD-14,103,103USD-12,723,689USD-12,092,776USD-12,747,697USD-4,600,038USD-5,931,253USD
    Ebitda-8,091,983USD-14,103,103USD-14,577,768USD-12,092,776USD-12,814,200USD-4,600,038USD-5,931,253USD
    Total Other Income Expense Net125,445USD0USD2USD-1USD133,006USD2USD-3USD
    Income Tax Expense—-14,088,999,897USD-14,577USD-1,224USD-66,503USD-4,598USD-5,934USD
    Ebit—-14,103,103USD-29,156,000USD-24,186,000USD-12,880,703USD-4,600,038USD-5,931,253USD
    Depreciation And Amortization—14,103,103USD14,578,000USD12,093,000USD66,503USD4,600USD5,931USD
    Interest Expense———1,224USD66,503USD0USD0USD
    Net Income Applicable To Common Shares———-12,092,776USD-12,747,697USD-4,600,038USD-5,931,253USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets10,984,777USD9,539,952USD6,105,211USD6,157,858USD4,805,461USD3,857,963USD5,982,759USD6,580,392USD
    Total Liabilities2,832,746USD———————
    Total Current Liabilities2,832,746USD2,526,809USD2,468,175USD2,591,527USD2,494,062USD3,242,842USD3,318,765USD3,152,917USD
    Total Stockholder Equity8,152,031USD7,013,143USD3,637,036USD3,566,331USD2,311,399USD615,121USD2,663,994USD3,427,475USD
    Total Equity Including Noncontrolling Interest8,152,031USD———————
    Net Receivables95,307USD56,313USD40,208USD40,208USD—51,127USD97,373USD51,127USD
    Accounts Payable2,832,746USD—————19,097USD10,134USD
    Common Stock4,683USD3,389USD1,800USD1,470USD22,398USD17,031USD16,770USD15,996USD
    Retained Earnings-79,223,649USD-76,969,476USD-73,710,218USD-71,717,428USD-69,471,149USD-67,321,956USD-64,540,165USD-61,718,568USD
    Other Current Assets—228,826USD158,201USD53,522USD161,574USD100,123USD122,822USD168,407USD
    Total Liab—2,526,809USD2,468,175USD2,591,527USD2,494,062USD3,242,842USD3,318,765USD3,152,917USD
    Other Current Liab—2,526,809USD2,468,175USD2,591,527USD2,494,062USD3,242,842USD3,318,765USD3,152,917USD
    Capital Stock—3,389USD1,800USD1,470USD22,398USD17,031USD16,770USD15,996USD
    Other Assets—285,139,000USD198,409,000USD93,730,000USD161,574,000USD151,250,000USD220,195,000USD219,534,000USD
    Cash—9,254,813USD5,906,802USD6,064,128USD4,643,887USD3,706,713USD5,762,564USD6,360,858USD
    Cash And Short Term Investments—9,254,813USD5,906,802USD6,064,128USD4,643,887USD3,706,713USD5,762,564USD6,360,858USD
    Total Current Assets—9,539,952USD6,105,211USD6,157,858USD4,805,461USD3,857,963USD5,982,759USD6,580,392USD
    Net Debt—-9,254,813USD-5,906,802USD-6,064,128USD-4,643,887USD-3,706,713USD-5,762,564USD-6,360,858USD
    Common Stock Shares Outstanding—1,499,000shares1,625,805shares1,190,266shares1,001,950shares851,550shares818,150shares791,250shares
    Non Current Assets Total—0USD0USD0USD0USD151,250,000USD0USD0USD
    Non Current Liabilities Total—0USD0USD0USD0USD0USD0USD0USD
    Net Working Capital—7,013,143USD3,637,036USD3,566,331USD2,311,399USD615,121USD2,663,994USD3,427,475USD
    Unclassified Non Current Assets—-285,139,000USD-198,409,000USD-93,730,000USD-161,574,000USD—-220,195,000USD-219,534,000USD
    Unclassified Equity—83,975,841USD77,343,654USD75,280,819USD71,737,752USD67,903,015USD67,170,619USD65,114,051USD
    Short Term Investments——————5,756,801,436USD—
    Unclassified Current Assets——————-5,756,801,436USD—
    Accumulated Other Comprehensive Income———————0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Assets3,857,963USD7,709,123USD9,376,706USD13,254,150USD3,224,020USD2,531,425USD
    Other Current Assets100,123USD105,776USD264,955USD295,304USD48,609USD48,103USD
    Total Liab3,242,842USD3,042,438USD2,061,685USD843,909USD522,434USD1,711,571USD
    Total Stockholder Equity615,121USD4,666,685USD7,315,021USD12,410,241USD2,701,586USD819,854USD
    Other Current Liab3,242,842USD3,042,438USD2,061,685USD843,909USD455,931USD1,711,571USD
    Common Stock17,031USD14,468USD11,628USD10,216USD16,502,198USD10,020,428USD
    Capital Stock17,031USD14,468USD11,628USD10,216USD16,502,198USD10,020,428USD
    Retained Earnings-67,321,956USD-53,218,853USD-38,641,085USD-26,548,309USD-13,800,612USD-9,200,574USD
    Other Assets151,250,000USD234,935,000USD264,955USD295,304,000USD——
    Cash3,706,713USD7,474,188USD9,111,751USD12,958,846USD3,175,411USD2,483,322USD
    Cash And Short Term Investments3,706,713USD7,474,188USD9,111,751USD12,958,846USD3,175,411USD2,483,322USD
    Total Current Assets3,857,963USD7,709,123USD9,376,706USD13,254,150USD3,224,020USD2,531,425USD
    Total Current Liabilities3,242,842USD3,042,438USD2,061,685USD843,909USD472,556USD1,711,571USD
    Net Debt-3,706,713USD-7,474,188USD-9,111,751USD-12,958,846USD-3,108,908USD-2,483,322USD
    Net Receivables51,127USD129,159USD————
    Common Stock Shares Outstanding851,550shares633,600shares540,800shares510,800shares495,800shares477,050shares
    Non Current Assets Total3,854,105,037USD0USD0USD0USD0USD0USD
    Non Current Liabilities Total0USD0USD2,062,000USD0USD49,878USD0USD
    Net Working Capital615,121USD4,666,685USD7,315,021USD12,410,241USD2,751,464USD819,854USD
    Unclassified Non Current Assets3,702,855,037USD-234,935,000USD—-295,304,000USD——
    Unclassified Equity67,903,015USD57,856,602USD84,573,935USD65,486,427USD-2,701,586USD—
    Accounts Payable—3,809USD29,539USD63,374USD—2,304USD
    Accumulated Other Comprehensive Income——-38,641,085USD-26,548,309USD-13,800,612USD-9,200,574USD
    Net Tangible Assets——7,315,021USD12,410,241USD2,701,586USD819,854USD
    Unclassified Non Current Liabilities——2,062,000USD———
    Short Term Debt————16,625USD—
    Short Long Term Debt————16,625USD—
    Short Long Term Debt Total————66,503USD—
    Long Term Debt————49,878USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Stock Based Compensation458,824USD
    Change To Liabilities411,803USD
    Change In Working Capital411,803USD
    Operating Cash Flow-3,117,485USD
    Financing Cash Flow6,217,771USD
    Change In Cash3,100,286USD
    End Cash Flow10,656,386USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-1,680,982USD-1,578,276USD-1,992,790USD-2,246,279USD-2,149,193USD-2,781,791USD-2,821,597USD-4,121,826USD
    Stock Based Compensation258,287,000USD375,794USD339,852USD410,396USD443,678USD538,371USD466,591USD1,230,498USD
    Other Non Cash Items319,287USD-4,265,726,762USD339,852USD3,733,936,104USD306USD-49,046USD440,319USD256,626USD
    Change To Account Receivables-7,896USD-8,209USD-10,919USD-40,208USD51,127USD46,246USD-46,246USD-51,127USD
    Change In Working Capital-45,838USD17,742USD-228,031USD165,309USD-345,984USD-6,978USD165,187USD11,049USD
    Total Cash From Operating Activities-1,407,533USD-1,184,740USD-1,880,969USD-1,670,574USD-2,051,499USD-2,250,398USD-2,189,819USD-2,880,279USD
    Capital Expenditures-3USD0USD-1USD-4USD0USD0USD0USD0USD
    Free Cash Flow-1,407,530USD-1,184,740USD-1,880,969USD-1,670,574USD-2,051,499USD-2,250,398USD-2,189,819USD-2,880,279USD
    Total Cash From Financing Activities3,106,246USD2,834,038USD1,723,643USD3,090,815USD2,988,673USD194,547USD1,591,525USD320,211USD
    Sale Purchase Of Stock3,106,246,000USD863,232,000USD2,334,945,000USD610,262,000USD————
    Issuance Of Capital Stock3,106,246USD1,473,494USD1,724,683USD610,262USD2,988,673USD194,547USD1,591,525USD320,211USD
    Change In Cash1,698,713USD1,649,298USD-157,326USD1,420,241USD937,174USD-2,055,851USD-598,294USD-2,560,068USD
    Begin Period Cash Flow7,556,100USD5,906,802USD6,064,128USD4,643,887USD3,706,713USD5,762,564USD6,360,858USD8,920,926USD
    End Period Cash Flow9,254,813USD7,556,100USD5,906,802USD6,064,128USD4,643,887USD3,706,713USD5,762,564USD6,360,858USD
    Other Cashflows From Financing Activities3,106,246,000USD-3,239,370,512USD-1,040USD2,480,553USD-327USD200,758,210USD-475USD320,211USD
    Unclassified Operating Cash Flow-258,287,000USD4,265,726,762USD—-3,733,936,104USD————
    Unclassified Financing Cash Flow-6,209,385,754USD2,378,972,550USD-2,333,220,317USD-609,651,738USD—-200,758,210USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Net Income-7,966,538,000USD-14,103,103USD-14,577,768USD-12,092,776USD-12,747,697USD-4,600,038USD-5,931,253USD
    Stock Based Compensation1,247,401,000USD3,435,583USD3,766,110USD3,302,361USD6,742,455USD1,267,946USD900,431USD
    Other Non Cash Items-68,254,036USD-89USD227USD1,000USD850,262USD781,700USD-431USD
    Change To Account Receivables2,710USD78,032USD-129,159USD————
    Change In Working Capital-390,964USD284,089USD1,010,773USD1,248,125USD141,283USD-801,166USD1,045,556USD
    Total Cash From Operating Activities-6,787,782,000USD-10,383,431USD-9,800,885USD-7,542,290USD-5,013,697USD-3,351,558USD-3,985,266USD
    Capital Expenditures0USD0USD-5USD0USD-3USD0USD0USD
    Free Cash Flow-6,787,782,000USD-10,383,431USD-9,800,885USD-7,542,290USD-5,013,697USD-3,351,558USD-3,985,266USD
    Total Cash From Financing Activities10,637,169,000USD6,615,956USD8,163,322USD3,695,195USD14,797,132USD4,043,647USD4,455,435USD
    Sale Purchase Of Stock3,808,439,000USD0USD—————
    Issuance Of Capital Stock6,797,112USD6,405,757USD3,543,611USD3,695,182USD14,797,132USD3,977,144USD4,455,435USD
    Change In Cash3,849,387,000USD-3,767,475USD-1,637,563USD-3,847,095USD9,783,435USD692,089USD470,169USD
    Begin Period Cash Flow3,706,713,000USD7,474,188USD9,111,751USD12,958,846USD3,175,411USD2,483,322USD2,013,153USD
    End Period Cash Flow7,556,100,000USD3,706,713USD7,474,188USD9,111,751USD12,958,846USD3,175,411USD2,483,322USD
    Other Cashflows From Financing Activities10,626,530,791USD210,199USD2,219,072USD13USD14,797,132USD497USD454,980USD
    Unclassified Financing Cash Flow-3,797,800,791USD6,405,757USD2,400,639USD—-14,797,132USD——
    Change To Inventory——-980,753,001USD————
    Other Cashflows From Investing Activities——-5USD————
    Change To Liabilities———1,217,776USD387,978USD-800,660USD1,060,930USD
    Net Borrowings————0USD66,503USD66,503USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.